PDB Short entry for 5IFW HEADER SIGNALING PROTEIN 26-FEB-16 5IFW TITLE QUANTITATIVE INTERACTION MAPPING REVEALS AN EXTENDED UBIQUITIN TITLE 2 REGULATORY DOMAIN IN ASPL THAT DISRUPTS FUNCTIONAL P97 HEXAMERS AND TITLE 3 INDUCES CELL DEATH COMPND MOL_ID: 1; COMPND 2 MOLECULE: TETHER CONTAINING UBX DOMAIN FOR GLUT4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 317-504; COMPND 5 SYNONYM: ALVEOLAR SOFT PART SARCOMA CHROMOSOMAL REGION CANDIDATE GENE COMPND 6 1 PROTEIN,ALVEOLAR SOFT PART SARCOMA LOCUS,RENAL PAPILLARY CELL COMPND 7 CARCINOMA PROTEIN 17,UBX DOMAIN-CONTAINING PROTEIN 9; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE; COMPND 11 CHAIN: B; COMPND 12 SYNONYM: TER ATPASE,15S MG(2+)-ATPASE P97 SUBUNIT,VALOSIN-CONTAINING COMPND 13 PROTEIN,VCP; COMPND 14 EC: 3.6.4.6; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ASPSCR1, ASPL, RCC17, TUG, UBXD9, UBXN9; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA 2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PQLINKG; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: VCP; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_VARIANT: ROSETTA 2; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PQLINKG KEYWDS ASPL, P97, DISASSEMBLY, HEXAMER, EUBX, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.ROSKE,U.HEINEMANN REVDAT 3 10-JAN-24 5IFW 1 REMARK REVDAT 2 02-NOV-16 5IFW 1 JRNL REVDAT 1 26-OCT-16 5IFW 0 JRNL AUTH A.ARUMUGHAN,Y.ROSKE,C.BARTH,L.L.FORERO,K.BRAVO-RODRIGUEZ, JRNL AUTH 2 A.REDEL,S.KOSTOVA,E.MCSHANE,R.OPITZ,K.FAELBER,K.RAU, JRNL AUTH 3 T.MIELKE,O.DAUMKE,M.SELBACH,E.SANCHEZ-GARCIA,O.ROCKS, JRNL AUTH 4 D.PANAKOVA,U.HEINEMANN,E.E.WANKER JRNL TITL QUANTITATIVE INTERACTION MAPPING REVEALS AN EXTENDED UBX JRNL TITL 2 DOMAIN IN ASPL THAT DISRUPTS FUNCTIONAL P97 HEXAMERS. JRNL REF NAT COMMUN V. 7 13047 2016 JRNL REFN ESSN 2041-1723 JRNL PMID 27762274 JRNL DOI 10.1038/NCOMMS13047 REMARK 2 REMARK 2 RESOLUTION. 3.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.2_1309 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.89 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 20785 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1040 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.8889 - 6.4911 0.99 2942 156 0.2071 0.2270 REMARK 3 2 6.4911 - 5.1580 1.00 2844 149 0.2338 0.2587 REMARK 3 3 5.1580 - 4.5077 1.00 2805 148 0.2060 0.2415 REMARK 3 4 4.5077 - 4.0963 1.00 2802 148 0.2004 0.2355 REMARK 3 5 4.0963 - 3.8031 1.00 2796 147 0.2495 0.3100 REMARK 3 6 3.8031 - 3.5792 1.00 2778 146 0.2684 0.2961 REMARK 3 7 3.5792 - 3.4001 1.00 2778 146 0.3014 0.3502 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.410 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.890 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 56.21 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 7137 REMARK 3 ANGLE : 0.864 9664 REMARK 3 CHIRALITY : 0.054 1093 REMARK 3 PLANARITY : 0.004 1271 REMARK 3 DIHEDRAL : 14.235 2748 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5IFW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-FEB-16. REMARK 100 THE DEPOSITION ID IS D_1000218769. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JAN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20794 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.400 REMARK 200 RESOLUTION RANGE LOW (A) : 33.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.16800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.84400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.160 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER, PHASER REMARK 200 STARTING MODEL: 3CF1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2M AMMONIUM SULFATE, 0.1M BIS-TRIS PH REMARK 280 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y+1/2,-Z REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 71.67200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 104.18050 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 71.67200 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 104.18050 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 71.67200 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 104.18050 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 71.67200 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 104.18050 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 16930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 85900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -82.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 99.12900 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 500 REMARK 465 PRO A 501 REMARK 465 SER A 502 REMARK 465 PRO A 503 REMARK 465 LEU A 504 REMARK 465 GLY B 0 REMARK 465 SER B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 GLY B 4 REMARK 465 ALA B 5 REMARK 465 ASP B 6 REMARK 465 SER B 7 REMARK 465 LYS B 8 REMARK 465 GLY B 9 REMARK 465 ASP B 10 REMARK 465 ASP B 11 REMARK 465 LEU B 12 REMARK 465 LYS B 312 REMARK 465 ARG B 313 REMARK 465 GLU B 314 REMARK 465 LYS B 315 REMARK 465 THR B 316 REMARK 465 HIS B 317 REMARK 465 MET B 427 REMARK 465 ASP B 428 REMARK 465 LEU B 429 REMARK 465 ILE B 430 REMARK 465 ASP B 431 REMARK 465 LEU B 432 REMARK 465 GLU B 433 REMARK 465 TYR B 495 REMARK 465 PRO B 496 REMARK 465 VAL B 497 REMARK 465 GLU B 498 REMARK 465 HIS B 499 REMARK 465 PRO B 500 REMARK 465 ASP B 501 REMARK 465 LYS B 502 REMARK 465 PHE B 503 REMARK 465 LEU B 504 REMARK 465 LYS B 505 REMARK 465 PHE B 506 REMARK 465 GLY B 507 REMARK 465 MET B 508 REMARK 465 THR B 509 REMARK 465 PRO B 510 REMARK 465 SER B 511 REMARK 465 ALA B 585 REMARK 465 ARG B 586 REMARK 465 GLY B 587 REMARK 465 GLY B 588 REMARK 465 ASN B 589 REMARK 465 ILE B 590 REMARK 465 GLY B 591 REMARK 465 ASP B 592 REMARK 465 GLY B 593 REMARK 465 GLY B 594 REMARK 465 GLY B 595 REMARK 465 ALA B 596 REMARK 465 ALA B 597 REMARK 465 THR B 613 REMARK 465 LYS B 614 REMARK 465 LYS B 615 REMARK 465 THR B 761 REMARK 465 LEU B 762 REMARK 465 GLN B 763 REMARK 465 GLN B 764 REMARK 465 SER B 765 REMARK 465 ARG B 766 REMARK 465 GLY B 767 REMARK 465 PHE B 768 REMARK 465 GLY B 769 REMARK 465 SER B 770 REMARK 465 PHE B 771 REMARK 465 ARG B 772 REMARK 465 PHE B 773 REMARK 465 PRO B 774 REMARK 465 SER B 775 REMARK 465 GLY B 776 REMARK 465 ASN B 777 REMARK 465 GLN B 778 REMARK 465 GLY B 779 REMARK 465 GLY B 780 REMARK 465 ALA B 781 REMARK 465 GLY B 782 REMARK 465 PRO B 783 REMARK 465 SER B 784 REMARK 465 GLN B 785 REMARK 465 GLY B 786 REMARK 465 SER B 787 REMARK 465 GLY B 788 REMARK 465 GLY B 789 REMARK 465 GLY B 790 REMARK 465 THR B 791 REMARK 465 GLY B 792 REMARK 465 GLY B 793 REMARK 465 SER B 794 REMARK 465 VAL B 795 REMARK 465 TYR B 796 REMARK 465 THR B 797 REMARK 465 GLU B 798 REMARK 465 ASP B 799 REMARK 465 ASN B 800 REMARK 465 ASP B 801 REMARK 465 ASP B 802 REMARK 465 ASP B 803 REMARK 465 LEU B 804 REMARK 465 TYR B 805 REMARK 465 GLY B 806 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 471 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 496 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 512 CG CD CE NZ REMARK 470 GLU B 554 CG CD OE1 OE2 REMARK 470 GLU B 556 CG CD OE1 OE2 REMARK 470 LYS B 696 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OG1 THR B 330 OG1 THR B 330 2565 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 464 CA - CB - CG ANGL. DEV. = 14.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 369 72.97 50.94 REMARK 500 ARG A 400 -12.16 82.48 REMARK 500 ASN A 426 136.03 -177.47 REMARK 500 LEU A 472 -124.20 61.58 REMARK 500 ALA A 497 -167.19 -74.35 REMARK 500 ALA A 498 -9.64 -58.67 REMARK 500 ARG B 64 -12.26 76.60 REMARK 500 GLU B 305 70.51 56.57 REMARK 500 ARG B 362 -76.38 -111.06 REMARK 500 ASN B 460 142.48 176.19 REMARK 500 ARG B 465 -20.53 78.45 REMARK 500 GLU B 466 64.74 36.80 REMARK 500 ALA B 570 136.25 -175.43 REMARK 500 ARG B 638 -70.88 -89.67 REMARK 500 ASN B 680 -59.96 -126.83 REMARK 500 ARG B 744 -72.47 -133.71 REMARK 500 ARG B 745 74.50 44.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU B 464 ARG B 465 31.57 REMARK 500 PHE B 742 ALA B 743 -145.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ADP B 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ADP B 902 DBREF 5IFW A 317 504 UNP Q9BZE9 ASPC1_HUMAN 317 504 DBREF 5IFW B 2 806 UNP P55072 TERA_HUMAN 2 806 SEQADV 5IFW GLY B 0 UNP P55072 EXPRESSION TAG SEQADV 5IFW SER B 1 UNP P55072 EXPRESSION TAG SEQRES 1 A 188 PRO VAL ASP ARG GLU PRO VAL VAL CYS HIS PRO ASP LEU SEQRES 2 A 188 GLU GLU ARG LEU GLN ALA TRP PRO ALA GLU LEU PRO ASP SEQRES 3 A 188 GLU PHE PHE GLU LEU THR VAL ASP ASP VAL ARG ARG ARG SEQRES 4 A 188 LEU ALA GLN LEU LYS SER GLU ARG LYS ARG LEU GLU GLU SEQRES 5 A 188 ALA PRO LEU VAL THR LYS ALA PHE ARG GLU ALA GLN ILE SEQRES 6 A 188 LYS GLU LYS LEU GLU ARG TYR PRO LYS VAL ALA LEU ARG SEQRES 7 A 188 VAL LEU PHE PRO ASP ARG TYR VAL LEU GLN GLY PHE PHE SEQRES 8 A 188 ARG PRO SER GLU THR VAL GLY ASP LEU ARG ASP PHE VAL SEQRES 9 A 188 ARG SER HIS LEU GLY ASN PRO GLU LEU SER PHE TYR LEU SEQRES 10 A 188 PHE ILE THR PRO PRO LYS THR VAL LEU ASP ASP HIS THR SEQRES 11 A 188 GLN THR LEU PHE GLN ALA ASN LEU PHE PRO ALA ALA LEU SEQRES 12 A 188 VAL HIS LEU GLY ALA GLU GLU PRO ALA GLY VAL TYR LEU SEQRES 13 A 188 GLU PRO GLY LEU LEU GLU HIS ALA ILE SER PRO SER ALA SEQRES 14 A 188 ALA ASP VAL LEU VAL ALA ARG TYR MET SER ARG ALA ALA SEQRES 15 A 188 GLY SER PRO SER PRO LEU SEQRES 1 B 807 GLY SER ALA SER GLY ALA ASP SER LYS GLY ASP ASP LEU SEQRES 2 B 807 SER THR ALA ILE LEU LYS GLN LYS ASN ARG PRO ASN ARG SEQRES 3 B 807 LEU ILE VAL ASP GLU ALA ILE ASN GLU ASP ASN SER VAL SEQRES 4 B 807 VAL SER LEU SER GLN PRO LYS MET ASP GLU LEU GLN LEU SEQRES 5 B 807 PHE ARG GLY ASP THR VAL LEU LEU LYS GLY LYS LYS ARG SEQRES 6 B 807 ARG GLU ALA VAL CYS ILE VAL LEU SER ASP ASP THR CYS SEQRES 7 B 807 SER ASP GLU LYS ILE ARG MET ASN ARG VAL VAL ARG ASN SEQRES 8 B 807 ASN LEU ARG VAL ARG LEU GLY ASP VAL ILE SER ILE GLN SEQRES 9 B 807 PRO CYS PRO ASP VAL LYS TYR GLY LYS ARG ILE HIS VAL SEQRES 10 B 807 LEU PRO ILE ASP ASP THR VAL GLU GLY ILE THR GLY ASN SEQRES 11 B 807 LEU PHE GLU VAL TYR LEU LYS PRO TYR PHE LEU GLU ALA SEQRES 12 B 807 TYR ARG PRO ILE ARG LYS GLY ASP ILE PHE LEU VAL ARG SEQRES 13 B 807 GLY GLY MET ARG ALA VAL GLU PHE LYS VAL VAL GLU THR SEQRES 14 B 807 ASP PRO SER PRO TYR CYS ILE VAL ALA PRO ASP THR VAL SEQRES 15 B 807 ILE HIS CYS GLU GLY GLU PRO ILE LYS ARG GLU ASP GLU SEQRES 16 B 807 GLU GLU SER LEU ASN GLU VAL GLY TYR ASP ASP ILE GLY SEQRES 17 B 807 GLY CYS ARG LYS GLN LEU ALA GLN ILE LYS GLU MET VAL SEQRES 18 B 807 GLU LEU PRO LEU ARG HIS PRO ALA LEU PHE LYS ALA ILE SEQRES 19 B 807 GLY VAL LYS PRO PRO ARG GLY ILE LEU LEU TYR GLY PRO SEQRES 20 B 807 PRO GLY THR GLY LYS THR LEU ILE ALA ARG ALA VAL ALA SEQRES 21 B 807 ASN GLU THR GLY ALA PHE PHE PHE LEU ILE ASN GLY PRO SEQRES 22 B 807 GLU ILE MET SER LYS LEU ALA GLY GLU SER GLU SER ASN SEQRES 23 B 807 LEU ARG LYS ALA PHE GLU GLU ALA GLU LYS ASN ALA PRO SEQRES 24 B 807 ALA ILE ILE PHE ILE ASP GLU LEU ASP ALA ILE ALA PRO SEQRES 25 B 807 LYS ARG GLU LYS THR HIS GLY GLU VAL GLU ARG ARG ILE SEQRES 26 B 807 VAL SER GLN LEU LEU THR LEU MET ASP GLY LEU LYS GLN SEQRES 27 B 807 ARG ALA HIS VAL ILE VAL MET ALA ALA THR ASN ARG PRO SEQRES 28 B 807 ASN SER ILE ASP PRO ALA LEU ARG ARG PHE GLY ARG PHE SEQRES 29 B 807 ASP ARG GLU VAL ASP ILE GLY ILE PRO ASP ALA THR GLY SEQRES 30 B 807 ARG LEU GLU ILE LEU GLN ILE HIS THR LYS ASN MET LYS SEQRES 31 B 807 LEU ALA ASP ASP VAL ASP LEU GLU GLN VAL ALA ASN GLU SEQRES 32 B 807 THR HIS GLY HIS VAL GLY ALA ASP LEU ALA ALA LEU CYS SEQRES 33 B 807 SER GLU ALA ALA LEU GLN ALA ILE ARG LYS LYS MET ASP SEQRES 34 B 807 LEU ILE ASP LEU GLU ASP GLU THR ILE ASP ALA GLU VAL SEQRES 35 B 807 MET ASN SER LEU ALA VAL THR MET ASP ASP PHE ARG TRP SEQRES 36 B 807 ALA LEU SER GLN SER ASN PRO SER ALA LEU ARG GLU THR SEQRES 37 B 807 VAL VAL GLU VAL PRO GLN VAL THR TRP GLU ASP ILE GLY SEQRES 38 B 807 GLY LEU GLU ASP VAL LYS ARG GLU LEU GLN GLU LEU VAL SEQRES 39 B 807 GLN TYR PRO VAL GLU HIS PRO ASP LYS PHE LEU LYS PHE SEQRES 40 B 807 GLY MET THR PRO SER LYS GLY VAL LEU PHE TYR GLY PRO SEQRES 41 B 807 PRO GLY CYS GLY LYS THR LEU LEU ALA LYS ALA ILE ALA SEQRES 42 B 807 ASN GLU CYS GLN ALA ASN PHE ILE SER ILE LYS GLY PRO SEQRES 43 B 807 GLU LEU LEU THR MET TRP PHE GLY GLU SER GLU ALA ASN SEQRES 44 B 807 VAL ARG GLU ILE PHE ASP LYS ALA ARG GLN ALA ALA PRO SEQRES 45 B 807 CYS VAL LEU PHE PHE ASP GLU LEU ASP SER ILE ALA LYS SEQRES 46 B 807 ALA ARG GLY GLY ASN ILE GLY ASP GLY GLY GLY ALA ALA SEQRES 47 B 807 ASP ARG VAL ILE ASN GLN ILE LEU THR GLU MET ASP GLY SEQRES 48 B 807 MET SER THR LYS LYS ASN VAL PHE ILE ILE GLY ALA THR SEQRES 49 B 807 ASN ARG PRO ASP ILE ILE ASP PRO ALA ILE LEU ARG PRO SEQRES 50 B 807 GLY ARG LEU ASP GLN LEU ILE TYR ILE PRO LEU PRO ASP SEQRES 51 B 807 GLU LYS SER ARG VAL ALA ILE LEU LYS ALA ASN LEU ARG SEQRES 52 B 807 LYS SER PRO VAL ALA LYS ASP VAL ASP LEU GLU PHE LEU SEQRES 53 B 807 ALA LYS MET THR ASN GLY PHE SER GLY ALA ASP LEU THR SEQRES 54 B 807 GLU ILE CYS GLN ARG ALA CYS LYS LEU ALA ILE ARG GLU SEQRES 55 B 807 SER ILE GLU SER GLU ILE ARG ARG GLU ARG GLU ARG GLN SEQRES 56 B 807 THR ASN PRO SER ALA MET GLU VAL GLU GLU ASP ASP PRO SEQRES 57 B 807 VAL PRO GLU ILE ARG ARG ASP HIS PHE GLU GLU ALA MET SEQRES 58 B 807 ARG PHE ALA ARG ARG SER VAL SER ASP ASN ASP ILE ARG SEQRES 59 B 807 LYS TYR GLU MET PHE ALA GLN THR LEU GLN GLN SER ARG SEQRES 60 B 807 GLY PHE GLY SER PHE ARG PHE PRO SER GLY ASN GLN GLY SEQRES 61 B 807 GLY ALA GLY PRO SER GLN GLY SER GLY GLY GLY THR GLY SEQRES 62 B 807 GLY SER VAL TYR THR GLU ASP ASN ASP ASP ASP LEU TYR SEQRES 63 B 807 GLY HET ADP B 901 27 HET ADP B 902 27 HETNAM ADP ADENOSINE-5'-DIPHOSPHATE FORMUL 3 ADP 2(C10 H15 N5 O10 P2) FORMUL 5 HOH *24(H2 O) HELIX 1 AA1 THR A 348 ALA A 369 1 22 HELIX 2 AA2 THR A 373 TYR A 388 1 16 HELIX 3 AA3 THR A 412 LEU A 424 1 13 HELIX 4 AA4 GLU A 466 VAL A 470 5 5 HELIX 5 AA5 GLU A 473 ALA A 480 1 8 HELIX 6 AA6 SER A 482 ARG A 496 1 15 HELIX 7 AA7 THR B 14 ASN B 21 1 8 HELIX 8 AA8 SER B 42 LEU B 49 1 8 HELIX 9 AA9 ASN B 85 LEU B 92 1 8 HELIX 10 AB1 ASN B 129 TYR B 134 1 6 HELIX 11 AB2 TYR B 134 LEU B 140 1 7 HELIX 12 AB3 GLY B 202 ILE B 206 5 5 HELIX 13 AB4 ARG B 210 HIS B 226 1 17 HELIX 14 AB5 HIS B 226 ILE B 233 1 8 HELIX 15 AB6 GLY B 250 THR B 262 1 13 HELIX 16 AB7 GLY B 271 LYS B 277 1 7 HELIX 17 AB8 GLY B 280 ASN B 296 1 17 HELIX 18 AB9 GLU B 305 ILE B 309 5 5 HELIX 19 AC1 GLU B 319 GLY B 334 1 16 HELIX 20 AC2 LYS B 336 ALA B 339 5 4 HELIX 21 AC3 ARG B 349 ILE B 353 5 5 HELIX 22 AC4 ASP B 354 ARG B 359 1 6 HELIX 23 AC5 ASP B 373 THR B 385 1 13 HELIX 24 AC6 ASP B 395 THR B 403 1 9 HELIX 25 AC7 VAL B 407 ARG B 424 1 18 HELIX 26 AC8 ALA B 439 LEU B 445 1 7 HELIX 27 AC9 THR B 448 SER B 459 1 12 HELIX 28 AD1 LEU B 482 VAL B 493 1 12 HELIX 29 AD2 GLY B 523 CYS B 535 1 13 HELIX 30 AD3 PRO B 545 LEU B 547 5 3 HELIX 31 AD4 THR B 549 GLY B 553 5 5 HELIX 32 AD5 ALA B 557 ALA B 569 1 13 HELIX 33 AD6 LEU B 579 ALA B 583 5 5 HELIX 34 AD7 ARG B 599 GLY B 610 1 12 HELIX 35 AD8 ARG B 625 ILE B 629 5 5 HELIX 36 AD9 ASP B 630 ARG B 635 5 6 HELIX 37 AE1 ASP B 649 ARG B 662 1 14 HELIX 38 AE2 ASP B 671 THR B 679 1 9 HELIX 39 AE3 SER B 683 ARG B 713 1 31 HELIX 40 AE4 ARG B 732 MET B 740 1 9 HELIX 41 AE5 SER B 748 MET B 757 1 10 SHEET 1 AA1 6 VAL A 323 CYS A 325 0 SHEET 2 AA1 6 VAL A 402 PHE A 407 -1 O GLN A 404 N VAL A 323 SHEET 3 AA1 6 VAL A 391 LEU A 396 -1 N VAL A 391 O PHE A 407 SHEET 4 AA1 6 ALA A 457 ALA A 464 1 O VAL A 460 N LEU A 396 SHEET 5 AA1 6 PHE A 431 ILE A 435 -1 N TYR A 432 O GLY A 463 SHEET 6 AA1 6 THR A 440 VAL A 441 -1 O THR A 440 N ILE A 435 SHEET 1 AA2 7 ARG B 25 ASP B 29 0 SHEET 2 AA2 7 LYS B 81 ARG B 83 1 O ILE B 82 N ILE B 27 SHEET 3 AA2 7 VAL B 38 LEU B 41 -1 N SER B 40 O ARG B 83 SHEET 4 AA2 7 GLU B 66 SER B 73 1 O ILE B 70 N VAL B 39 SHEET 5 AA2 7 THR B 56 LYS B 60 -1 N LEU B 59 O ALA B 67 SHEET 6 AA2 7 VAL B 99 GLN B 103 -1 O GLN B 103 N LEU B 58 SHEET 7 AA2 7 ARG B 25 ASP B 29 -1 N LEU B 26 O ILE B 100 SHEET 1 AA3 4 ILE B 151 GLY B 156 0 SHEET 2 AA3 4 ARG B 159 ASP B 169 -1 O PHE B 163 N PHE B 152 SHEET 3 AA3 4 ARG B 113 PRO B 118 -1 N LEU B 117 O LYS B 164 SHEET 4 AA3 4 VAL B 181 HIS B 183 1 O HIS B 183 N ILE B 114 SHEET 1 AA4 2 ILE B 126 THR B 127 0 SHEET 2 AA4 2 ILE B 437 ASP B 438 1 O ILE B 437 N THR B 127 SHEET 1 AA5 2 PRO B 145 ARG B 147 0 SHEET 2 AA5 2 TYR B 173 ILE B 175 -1 O CYS B 174 N ILE B 146 SHEET 1 AA6 5 PHE B 265 ASN B 270 0 SHEET 2 AA6 5 ALA B 299 ASP B 304 1 O PHE B 302 N ILE B 269 SHEET 3 AA6 5 VAL B 341 THR B 347 1 O MET B 344 N ILE B 303 SHEET 4 AA6 5 GLY B 240 TYR B 244 1 N LEU B 243 O ALA B 345 SHEET 5 AA6 5 ARG B 365 ASP B 368 1 O VAL B 367 N TYR B 244 SHEET 1 AA7 2 LYS B 389 LEU B 390 0 SHEET 2 AA7 2 ALA B 446 VAL B 447 1 O VAL B 447 N LYS B 389 SHEET 1 AA8 6 VAL B 469 GLU B 470 0 SHEET 2 AA8 6 ASN B 538 LYS B 543 -1 O PHE B 539 N GLU B 470 SHEET 3 AA8 6 CYS B 572 ASP B 577 1 O VAL B 573 N ASN B 538 SHEET 4 AA8 6 VAL B 617 THR B 623 1 O PHE B 618 N LEU B 574 SHEET 5 AA8 6 GLY B 513 TYR B 517 1 N PHE B 516 O GLY B 621 SHEET 6 AA8 6 GLN B 641 TYR B 644 1 O GLN B 641 N LEU B 515 CISPEP 1 THR A 436 PRO A 437 0 -17.84 CISPEP 2 PRO A 437 PRO A 438 0 -8.10 CISPEP 3 PHE A 455 PRO A 456 0 -14.62 CISPEP 4 ASP B 169 PRO B 170 0 9.66 CISPEP 5 SER B 171 PRO B 172 0 -5.45 CISPEP 6 ALA B 297 PRO B 298 0 0.96 CISPEP 7 PRO B 461 SER B 462 0 13.84 CISPEP 8 ALA B 570 PRO B 571 0 -6.04 CISPEP 9 ALA B 743 ARG B 744 0 -17.97 SITE 1 AC1 12 ASP B 205 GLY B 207 PRO B 247 GLY B 248 SITE 2 AC1 12 THR B 249 GLY B 250 LYS B 251 THR B 252 SITE 3 AC1 12 LEU B 253 HIS B 384 GLY B 408 ALA B 409 SITE 1 AC2 11 GLY B 480 PRO B 520 GLY B 521 CYS B 522 SITE 2 AC2 11 GLY B 523 LYS B 524 THR B 525 LEU B 526 SITE 3 AC2 11 ILE B 656 GLY B 684 ALA B 685 CRYST1 143.344 208.361 99.129 90.00 90.00 90.00 C 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006976 0.000000 0.000000 0.00000 SCALE2 0.000000 0.004799 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010088 0.00000